2m 2m 2m 2m 2m 2m 2m
MILESTONE PHARMA (MIST)
NASDAQ
$1.29+$0.009 (+0.70%)
Price as of Jul 14, 2026 7:44 AM EDT- $159.4MMarket Cap
- -7.25%1-Year Change
- BiotechnologyIndustry
MILESTONE PHARMA (MIST)
$1.29+$0.009 (+0.70%)
MIST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.28 | ||
Change | $0.00 (0.00%) | ||
Open | $1.29 | ||
High | $1.30 | ||
Low | $1.26 | ||
Previous Close | $1.28 | ||
Volume | 511,197 | ||
30-Day Average Volume | 1,478,031 | ||
1-Week Change | -3.03% | ||
1-Month Change | 0.79% | ||
1-Year Change | -7.25% | ||
3-Year Change | -64.35% | ||
5-Year Change | -77.26% | ||
Fundamentals | |||
Shares Outstanding | 124.5M | ||
Total Assets | $193.7M | ||
Market Cap | $159.4M | ||
Enterprise Value | $146.2M | ||
Period: QTR TTM FY | |||
Revenue | $238,000.00 | ||
Net Income | -$26.1M | ||
Free Cash Flow | -$16.1M | ||
EBIT | -$25.1M | ||
EBITDA | -$25.0M | ||
Net Working Capital | $171.3M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 614 | ||
P/B | 4 | ||
P/E | -6 | ||
PEG | N/A | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue